Who we are

Our story

The Linus Health story starts at the intersection of neuroscience and clinical practice—quite literally.

Two of our co-founders, David Bates, PhD, a scientist, investor, and entrepreneur—now our CEO—and Alvaro Pascual-Leone, MD, PhD, a world-renowned Harvard neurologist—Chief Medical Officer—crossed paths fortuitously at an event in 2018. They quickly discovered a shared interest in brain health and belief in the need for a fundamental shift towards more proactive detection of cognitive disorders and more personalized interventions to change their course. After a number of other fortuitous meetings and developments in the year that followed, they formed Linus Health in 2019 alongside two of David’s partners from Tamarisc Ventures, a venture capital firm focused on healthcare, technology, and real estate.

In 2020, Linus Health acquired Digital Cognition Technologies, a company that pioneered the modernization of the long-standing pen-and-paper Clock Drawing Test for cognitive impairment with the introduction of a digitized pen. Based on 10 years of R&D at MIT and Lahey Hospital & Medical Center, the innovation enhanced sensitivity and paved the way for the fully iPad-based DCTclock™, a quick and sensitive digital cognitive assessment that generates new insights from the drawing process itself, not just the final outputs. Building on its origins in drawing-based tests, Linus has expanded to deliver an expansive digital platform that couples objective cognitive tests with actionable guidance for both providers and patients.